These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2509407)

  • 21. [Effectiveness of the antibiotic from Pseudomonas fluorescens on the influenza virus].
    BICKEL H
    Arch Hyg Bakteriol; 1961 Nov; 145():475-80. PubMed ID: 13868964
    [No Abstract]   [Full Text] [Related]  

  • 22. [Isolation of anaerobic bacteria in samples from human clinical cases].
    Mateu Cortada CE; Berroa del Río M; Veiga Camuzzo MR; Martínez Fernández OM; Teijelo Famadas M; González Garriga M
    Rev Cubana Med Trop; 1986; 38(3):311-21. PubMed ID: 3299548
    [No Abstract]   [Full Text] [Related]  

  • 23. Purification and characterization of adhesive exopolysaccharides from Pseudomonas putida and Pseudomonas fluorescens.
    Read RR; Costerton JW
    Can J Microbiol; 1987 Dec; 33(12):1080-90. PubMed ID: 2451553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitroimidazoles, Part XXIII--activity of satranidazole series against anaerobic infections.
    Nagarajan K; Gowrishankar R; Arya VP; George T; Nair MD; Shenoy SJ; Sudarsanam V
    Indian J Exp Biol; 1992 Mar; 30(3):193-200. PubMed ID: 1512026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endotoxins of Pseudomonas fluorescens.
    Zdorovenko GM; Veremeychenko SN; Zakharova IYa ; Knirel YuA
    Adv Exp Med Biol; 1990; 256():131-5. PubMed ID: 2109500
    [No Abstract]   [Full Text] [Related]  

  • 26. Isolation of a new antibiotic from a species of Pseudomonas.
    Evans JR; Napier EJ; Yates P
    J Antibiot (Tokyo); 1976 Aug; 29(8):850-2. PubMed ID: 993124
    [No Abstract]   [Full Text] [Related]  

  • 27. Nitrosoimidazoles: highly bactericidal analogues of 5-nitroimidazole drugs.
    Ehlhardt WJ; Beaulieu BB; Goldman P
    J Med Chem; 1988 Feb; 31(2):323-9. PubMed ID: 3339605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial activities of nitrothiazole derivatives.
    Hof H; Zak O; Schweizer E; Denzler A
    J Antimicrob Chemother; 1984 Jul; 14(1):31-9. PubMed ID: 6384174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Direct quantitative method for evaluating the effect of biocides on Pseudomonas fluorescens in different culture media].
    Rodin VB; Zhigletsova SK; Akimova NA; Kholodenko VP
    Prikl Biokhim Mikrobiol; 2000; 36(6):701-5. PubMed ID: 11116916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative characteristics of lipopolysaccharides in various strains of Pseudomonas fluorescens].
    Zdorovenko GM; Veremeĭchenko SN; Zakharova IIa
    Mikrobiol Zh (1978); 1987; 49(4):12-7. PubMed ID: 3150497
    [No Abstract]   [Full Text] [Related]  

  • 31. [The core oligosaccharides of Pseudomonas fluorescens lipopolysaccharides].
    Veremeĭchenko SN
    Mikrobiol Zh (1978); 1987; 49(5):18-22. PubMed ID: 3150501
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of natural product compounds as quorum sensing inhibitors in Pseudomonas fluorescens P07 through virtual screening.
    Ding T; Li T; Li J
    Bioorg Med Chem; 2018 Aug; 26(14):4088-4099. PubMed ID: 30100021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of nim-class genes, encoding nitroimidazole resistance, among different species of Gram-negative anaerobic bacteria isolated in Athens, Greece.
    Katsandri A; Avlamis A; Pantazatou A; Houhoula DP; Papaparaskevas J
    J Antimicrob Chemother; 2006 Sep; 58(3):705-6. PubMed ID: 16867996
    [No Abstract]   [Full Text] [Related]  

  • 34. In-vitro susceptibility of Pseudomonas species to fifteen antimicrobial agents.
    Rolston KV; Anaissie EA; Bodey GP
    J Antimicrob Chemother; 1987 Feb; 19(2):193-6. PubMed ID: 3106300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological characterization of ice nucleation proteins from Pseudomonas syringae, Pseudomonas fluorescens, and Erwinia herbicola.
    Deininger CA; Mueller GM; Wolber PK
    J Bacteriol; 1988 Feb; 170(2):669-75. PubMed ID: 3123461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Origanum vulgare essential oil on biofilm formation and motility capacity of Pseudomonas fluorescens strains isolated from discoloured Mozzarella cheese.
    Rossi C; Chaves-López C; Serio A; Anniballi F; Valbonetti L; Paparella A
    J Appl Microbiol; 2018 May; 124(5):1220-1231. PubMed ID: 29356249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3959-62. PubMed ID: 16982780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sperabillins, new antibacterial antibiotics with potent in vivo activity. Taxonomy, fermentation, isolation and biological activity.
    Katayama N; Nozaki Y; Tsubotani S; Kondo M; Harada S; Ono H
    J Antibiot (Tokyo); 1992 Jan; 45(1):10-9. PubMed ID: 1372306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-656,575 (OCP-9-176): a novel oxacephem. In vitro activity against aerobic and anaerobic clinical bacterial isolates.
    Weissberger B; Abruzzo GK; Fromtling RA; Valiant ME; Shungu DL; Gadebusch HH
    J Antibiot (Tokyo); 1988 Aug; 41(8):1130-6. PubMed ID: 3170346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility patterns of anaerobic bacteria in relation to therapy.
    García-Rodríguez J; García-Sánchez J
    Chemioterapia; 1987 Jun; 6(2 Suppl):49-52. PubMed ID: 3509479
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.